AI is no longer a futuristic concept in pathology; it is already making a tangible impact. AI algorithms are trained on vast datasets of digitized slides to recognize complex patterns that may be difficult for the human eye to consistently identify.

Launched by the Alzheimer’s Drug Discovery Foundation (ADDF) in partnership with major philanthropists and organizations, this program is on a mission to revolutionize how we diagnose and monitor Alzheimer’s and other dementias.

Have you ever heard the saying, "the eyes are the window to the soul"? In medicine, a more accurate phrase might be, "the eyes are a window to your health." A new and exciting field called ocular phenotyping is proving just how true that is, offering a non-invasive way to spot signs of diseases throughout the body, from Alzheimer's to diabetes.

The Asia Pacific (APAC) region is experiencing a healthcare revolution, driven by the rapid adoption of digital technologies.

Precision medicine requires a much broader and deeper view of a patient than traditional medicine.

What if the true BCI revolution isn't a surgical one? What if it's already here, on your head, in a pair of headphones?